On January 19, 2019, U.S. Virgin Islands Gov. Albert Bryan Jr. signed into law the Medical Cannabis Patient Care Act, setting up a medical cannabis program for both Virgin Islands residents and medical tourists.
The Virgin Islands Medical Cannabis Patient Care Act allows qualified patients to obtain, possess and consume medical cannabis for therapeutic purposes. The qualifying conditions are: cancer, glaucoma, HIV/AIDS, hepatitis C, amyotrophic lateral sclerosis, Crohn’s disease, ulcerative colitis, agitation of Alzheimer’s disease, PTSD, traumatic brain injury, hospice care, Parkinson’s disease, Huntington’s disease, neuropathic pain, autism, arthritis, diabetes, chronic pain, opiate use disorder, or the treatment of these conditions or conditions that cause cachexia or wasting, severe nausea, seizures, or severe and persistent muscle spasms. Qualifying residents can possess up to four ounces of medical cannabis at a time and possession for qualifying non-residents will be limited at three ounces.
The act also establishes cultivation facilities (up to 1,000 plants), cannabis testing facilities, cannabis product manufacturing facilities, and dispensaries. An Office of Cannabis Regulation (OCR) will publish rules within four months, and the issuance of licenses will start three months after that.
Taxes and fees:
- Application fees range from $500 to $5,000
- A 10% excise fee is levied on transfers to dispensaries and manufacturing facilities.
- A 5% excise fee is levied on sales to patients.
In addition to the U.S. Virgin Islands, other U.S. territories that have approved medical cannabis include Guam and Puerto Rico.
- Cannabis Industry
- Cannabis Australia
- Cannabis Canada
- Cannabis Europe
- Cannabis Mexico
- Cannabis US
- Cannabis Market
- Cannabis News
- Cannabis Start-Up
- Hemp Industry